Literature DB >> 26409636

National Trends in Pulmonary Embolism Hospitalization Rates and Outcomes for Adults Aged ≥65 Years in the United States (1999 to 2010).

Karl E Minges1, Behnood Bikdeli2, Yun Wang3, Nancy Kim4, Jeptha P Curtis5, Mayur M Desai6, Harlan M Krumholz7.   

Abstract

Little is known about national trends of pulmonary embolism (PE) hospitalizations and outcomes in older adults in the context of recent diagnostic and therapeutic advances. Therefore, we conducted a retrospective cohort study of 100% Medicare fee-for-service beneficiaries hospitalized from 1999 to 2010 with a principal discharge diagnosis code for PE. The adjusted PE hospitalization rate increased from 129/100,000 person-years in 1999 to 302/100,000 person-years in 2010, a relative increase of 134% (p <0.001). Black patients had the highest rate of increase (174 to 548/100,000 person-years) among all age, gender, and race categories. The mean (standard deviation) length of hospital stay decreased from 7.6 (5.7) days in 1999 to 5.8 (4.4) days in 2010, and the proportion of patients discharged to home decreased from 51.1% (95% confidence interval [CI] 50.5 to 51.6) to 44.1% (95% CI 43.7 to 44.6), whereas more patients were discharged with home health care and to skilled nursing facilities. The in-hospital mortality rate decreased from 8.3% (95% CI 8.0 to 8.6) in 1999 to 4.4% (95% CI 4.2 to 4.5) in 2010, as did adjusted 30-day (from 12.3% [95% CI 11.9 to 12.6] to 9.1% [95% CI 8.5 to 9.7]) and 6-month mortality rates (from 23.0% [95% CI 22.5 to 23.4] to 19.6% [95% CI 18.8 to 20.5]). There were no significant racial differences in mortality rates by 2010. There was no change in the adjusted 30-day all-cause readmission rate from 1999 to 2010. In conclusion, PE hospitalization rates increased substantially from 1999 to 2010, with a higher rate for black patients. All mortality rates decreased but remained high. The increase in hospitalization rates and continued high mortality and readmission rates confirm the significant burden of PE for older adults.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26409636      PMCID: PMC4841688          DOI: 10.1016/j.amjcard.2015.07.068

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  28 in total

1.  Improving Practices in US Hospitals to Prevent Venous Thromboembolism: lessons from ENDORSE.

Authors:  Frederick A Anderson; Samuel Z Goldhaber; Victor F Tapson; Jean-Francois Bergmann; Ajay K Kakkar; Bruno Deslandes; Wei Huang; Alexander T Cohen
Journal:  Am J Med       Date:  2010-12       Impact factor: 4.965

2.  Ethnic differences in out-of-hospital fatal pulmonary embolism.

Authors:  Yingying Tang; Barbara Sampson; Stephanie Pack; Krunal Shah; Sung Yon Um; Dawei Wang; Tao Wang; Mechthild Prinz
Journal:  Circulation       Date:  2011-05-09       Impact factor: 29.690

3.  Evaluation of the predictive value of ICD-9-CM coded administrative data for venous thromboembolism in the United States.

Authors:  Richard H White; Martina Garcia; Banafsheh Sadeghi; Daniel J Tancredi; Patricia Zrelak; Joanne Cuny; Pradeep Sama; Harriet Gammon; Stephen Schmaltz; Patrick S Romano
Journal:  Thromb Res       Date:  2010-04-28       Impact factor: 3.944

4.  Surveillance for deep vein thrombosis and pulmonary embolism: recommendations from a national workshop.

Authors:  Gary E Raskob; Roy Silverstein; Dale W Bratzler; John A Heit; Richard H White
Journal:  Am J Prev Med       Date:  2010-04       Impact factor: 5.043

5.  Time trends in pulmonary embolism in the United States: evidence of overdiagnosis.

Authors:  Renda Soylemez Wiener; Lisa M Schwartz; Steven Woloshin
Journal:  Arch Intern Med       Date:  2011-05-09

6.  Developing public health surveillance for deep vein thrombosis and pulmonary embolism.

Authors:  Michele G Beckman; Scott D Grosse; Kristy M Kenney; Althea M Grant; Hani K Atrash
Journal:  Am J Prev Med       Date:  2011-12       Impact factor: 5.043

7.  Venous thromboembolism in adult hospitalizations - United States, 2007-2009.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2012-06-08       Impact factor: 17.586

Review 8.  How I diagnose acute pulmonary embolism.

Authors:  Menno V Huisman; Frederikus A Klok
Journal:  Blood       Date:  2013-04-16       Impact factor: 22.113

9.  Hestia criteria can safely select patients with pulmonary embolism for outpatient treatment irrespective of right ventricular function.

Authors:  W Zondag; L M A Vingerhoets; M F Durian; A Dolsma; L M Faber; B I Hiddinga; H M A Hofstee; A D M Hoogerbrugge; M M C Hovens; G Labots; T Vlasveld; M J M de Vreede; L J M Kroft; M V Huisman
Journal:  J Thromb Haemost       Date:  2013-04       Impact factor: 5.824

Review 10.  Iatrogenic disease in the elderly: risk factors, consequences, and prevention.

Authors:  Sompol Permpongkosol
Journal:  Clin Interv Aging       Date:  2011-03-21       Impact factor: 4.458

View more
  16 in total

1.  Sex disparities in hospitalization and mortality rates for venous thromboembolism.

Authors:  Sola Mansour; Ghazi Alotaibi; Cynthia Wu; Khalid Alsaleh; Michael Sean McMurtry
Journal:  J Thromb Thrombolysis       Date:  2017-08       Impact factor: 2.300

2.  Rationale, Design and Methodology of the Computerized Registry of Patients with Venous Thromboembolism (RIETE).

Authors:  Behnood Bikdeli; David Jimenez; Mayra Hawkins; Salvador Ortíz; Paolo Prandoni; Benjamin Brenner; Hervé Decousus; Frederick A Masoudi; Javier Trujillo-Santos; Harlan M Krumholz; Manuel Monreal
Journal:  Thromb Haemost       Date:  2018-01-05       Impact factor: 5.249

3.  The accuracy of combined use of troponin and red cell distribution width in predicting mortality of patients with acute pulmonary embolism.

Authors:  Selçuk Yazıcı; Tuncay Kırış; Ufuk S Ceylan; Şükrü Akyüz; Ahmet O Uzun; Recep Hacı; Sait Terzi; Abdullah Doğan; Ayşe Emre; Kemal Yeşilçimen
Journal:  Wien Klin Wochenschr       Date:  2016-09-19       Impact factor: 1.704

4.  Reasons for Differences in the Incidence of Venous Thromboembolism in Black Versus White Americans.

Authors:  Aaron R Folsom; Saonli Basu; Ching-Ping Hong; Susan R Heckbert; Pamela L Lutsey; Wayne D Rosamond; Mary Cushman
Journal:  Am J Med       Date:  2019-04-04       Impact factor: 4.965

5.  Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The CVRN VTE Study.

Authors:  Margaret C Fang; Dongjie Fan; Sue Hee Sung; Daniel M Witt; John R Schmelzer; Marc S Williams; Steven H Yale; Christine Baumgartner; Alan S Go
Journal:  Am J Med       Date:  2019-06-25       Impact factor: 4.965

Review 6.  Epidemiology and prevention of venous thromboembolism.

Authors:  Pamela L Lutsey; Neil A Zakai
Journal:  Nat Rev Cardiol       Date:  2022-10-18       Impact factor: 49.421

7.  National and Regional Trends in Deep Vein Thrombosis Hospitalization Rates, Discharge Disposition, and Outcomes for Medicare Beneficiaries.

Authors:  Karl E Minges; Behnood Bikdeli; Yun Wang; Robert R Attaran; Harlan M Krumholz
Journal:  Am J Med       Date:  2018-06-23       Impact factor: 4.965

8.  Vena Caval Filter Utilization and Outcomes in Pulmonary Embolism: Medicare Hospitalizations From 1999 to 2010.

Authors:  Behnood Bikdeli; Yun Wang; Karl E Minges; Nihar R Desai; Nancy Kim; Mayur M Desai; John A Spertus; Frederick A Masoudi; Brahmajee K Nallamothu; Samuel Z Goldhaber; Harlan M Krumholz
Journal:  J Am Coll Cardiol       Date:  2016-03-08       Impact factor: 24.094

9.  Epidemiology and diagnosis of pulmonary embolism in lung cancer patients: is there a role for age adjusted D-dimers cutoff?

Authors:  I Anagnostopoulos; S Lagou; M K Spanorriga; K Tavernaraki; G Poulakou; K N Syrigos; L Thanos
Journal:  J Thromb Thrombolysis       Date:  2020-05       Impact factor: 2.300

Review 10.  Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.

Authors:  Susan R Kahn; David R Morrison; Gisèle Diendéré; Alexandre Piché; Kristian B Filion; Adi J Klil-Drori; James D Douketis; Jessica Emed; André Roussin; Vicky Tagalakis; Martin Morris; William Geerts
Journal:  Cochrane Database Syst Rev       Date:  2018-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.